US Patent Issued to TWILIGHT BIOSCIENCE on Sept. 29 for "HERV-K (HML-2) Env analog fusion proteins for antigen specific immunotherapy and methods of use" (Maryland, Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,270, issued on Sept. 29, was assigned to TWILIGHT BIOSCIENCE INC. (Topsfield, Mass.).

"HERV-K (HML-2) Env analog fusion proteins for antigen specific immunotherapy and methods of use" was invented by Marta Garcia Montojo (Silver Spring, Md.), Ajay Verma (Rehoboth, Mass.) and Thomas M. Lancaster (Wenham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides recombinantly manufactured fusion proteins comprising a HERV-K (HML-2) Env protein fragment or an analog thereof linked to a human Fc fragment. Embodiments include the administration of the fusion proteins to patients having a disease or a disorder with the intentio...